1-3 of 3
Zuhair Ballas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prevalence and the Impact of Hypogammaglobulinemia in Newly Diagnosed, Untreated Diffuse Large B Cell Lymphoma

Namrata Singh, MD, Sarah L Mott, Ashley Noel McCarthy, MPH, Sergei Syrbu, MD PhD, Thomas M. Habermann, MD, Andrew L. Feldman, MD, Susan L Slager, PhD, Grzegorz Nowakowski, MD, Thomas E. Witzig, MD, Umar Farooq, MD, James R. Cerhan, MD PhD, Zuhair Ballas, Brian K. Link, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1604.
https://doi.org/10.1182/blood-2019-122737
Published: 2019
Journal Articles

A Phase I Trial of CpG-7909, Rituximab Immunotherapy, and Y90 Zevalin Radioimmunotherapy for Patients (Pts) with Previously Treated CD20+ Non-Hodgkin Lymphoma (NHL).

Thomas E. Witzig, MD, Gregory A. Wiseman, MD, George Weiner, MD, Stephen M. Ansell, MD, PHD, Ivana Micallef, MD, Thomas M. Habermann, MD, Clive S. Zent, MD, David J. Inwards, MD, Tait Shanafelt, MD, Luis Porrata, MD, Matthew J. Maurer, MS, Cristine Allmer, Zuhair Ballas, MD
Journal: Blood
Blood (2007) 110 (11): 124.
https://doi.org/10.1182/blood.V110.11.124.124
Published: 2007
Journal Articles

Immunostimulatory Oligodeoxynucleotides Containing CpG Motifs Enhance the Efficacy of Monoclonal Antibody Therapy of Lymphoma

James E. Wooldridge, Zuhair Ballas, Arthur M. Krieg, George J. Weiner
Journal: Blood
Blood (1997) 89 (8): 2994–2998.
https://doi.org/10.1182/blood.V89.8.2994
Published: 1997